Skye Bioscience SG&A Expense (TTM) Analysis

Skye Bioscience Inc (SKYE)

3.54 -0.03 (-0.84%) USD | NASDAQ | Oct 04, 16:00

3.55 +0.01 (+0.28%) After-Hours: 17:28

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
June 30, 2024	13.26M
March 31, 2024	10.14M
December 31, 2023	7.852M
September 30, 2023	6.898M
June 30, 2023	5.803M
March 31, 2023	6.388M
December 31, 2022	6.095M
September 30, 2022	5.902M
June 30, 2022	6.253M
March 31, 2022	5.411M
December 31, 2021	4.916M
September 30, 2021	4.517M
June 30, 2021	4.218M
March 31, 2021	4.061M
December 31, 2020	4.345M
September 30, 2020	4.523M
June 30, 2020	4.321M
March 31, 2020	4.612M
December 31, 2019	4.395M
September 30, 2019	4.345M
June 30, 2019	4.333M
March 31, 2019	4.330M
December 31, 2018	4.363M
September 30, 2018	4.201M

Date	Value
June 30, 2018	3.896M
March 31, 2018	3.486M
December 31, 2017	3.548M
September 30, 2017	3.280M
June 30, 2017	3.383M
March 31, 2017	3.735M
December 31, 2016	3.532M
September 30, 2016	3.694M
June 30, 2016	3.662M
March 31, 2016	3.953M
December 31, 2015	3.741M
September 30, 2015	4.598M
June 30, 2015	4.517M
March 31, 2015	3.237M
December 31, 2014	2.411M
September 30, 2014	0.7719M
July 31, 2014	0.1493M
April 30, 2014	0.1553M
January 31, 2014	0.1494M
October 31, 2013	0.1485M
July 31, 2013	0.1142M
April 30, 2013	0.0749M
January 31, 2013	0.0353M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

4.061M

Minimum

Mar 2021

13.26M

Maximum

Jun 2024

5.996M

Average

5.411M

Median

Mar 2022

SG&A Expense (TTM) Benchmarks